Tigutcystatin, a cysteine protease inhibitor from Triatoma infestans midgut expressed in response to Trypanosoma cruzi  by Buarque, Diego S. et al.
Biochemical and Biophysical Research Communications 413 (2011) 241–247Contents lists available at SciVerse ScienceDirect
Biochemical and Biophysical Research Communications
journal homepage: www.elsevier .com/locate /ybbrcTigutcystatin, a cysteine protease inhibitor from Triatoma infestans midgut
expressed in response to Trypanosoma cruzi
Diego S. Buarque a, Letícia M.N. Spindola a, Rafael M. Martins c, Glória R.C. Braz b, Aparecida S. Tanaka a,⇑
aDepartment of Biochemistry, Universidade Federal de São Paulo, Escola Paulista de Medicina, 04044-020 São Paulo, SP, Brazil
bDepartment of Biochemistry, Instituto de Química, Universidade Federal do Rio de Janeiro, 21941-909 Rio de Janeiro, Brazil
cBiology of Host Parasite Interactions Unit, Institute Pasteur, 75015 Paris, France
a r t i c l e i n f oArticle history:
Received 12 August 2011
Available online 22 August 2011
Keywords:
Cruzipain
Cysteine protease inhibitor
Tigutcystatin
Triatoma infestans
Trypanosoma cruzi0006-291X  2011 Elsevier Inc.
doi:10.1016/j.bbrc.2011.08.078
⇑ Corresponding author.
E-mail address: Tanaka.bioq@epm.br (A.S. Tanaka)
Open access under the Ea b s t r a c t
The insect Triatoma infestans is a vector of Trypanosoma cruzi, the etiological agent of Chagas disease. A
cDNA library was constructed from T. infestans anterior midgut, and 244 clones were sequenced. Among
the EST sequences, an open reading frame (ORF) with homology to a cystatin type 2 precursor was iden-
tiﬁed. Then, a 288-bp cDNA fragment encoding mature cystatin (lacking signal peptide) named Tigutcyst-
atin was cloned fused to a N-terminal His tag in pET-14b vector, and the protein expressed in Escherichia
coli strain Rosetta gami. Tigutcystatin puriﬁed and cleaved by thrombin to remove His tag presented
molecular mass of 11 kDa and 10,137 Da by SDS–PAGE and MALDI-TOF mass spectrometry, respectively.
Puriﬁed Tigutcystatin was shown to be a tight inhibitor towards cruzain, a T. cruzi cathepsin L-like
enzyme (Ki = 3.29 nM) and human cathepsin L (Ki = 3.78 nM). Tissue speciﬁc expression analysis showed
that Tigutcystatin was mostly expressed in anterior midgut, although ampliﬁcation in small intestine was
also detected by semi quantitative RT-PCR. qReal time PCR conﬁrmed that Tigutcystatin mRNA is signif-
icantly up-regulated in anterior midgut when T. infestans is infected with T. cruzi. Together, these results
indicate that Tigutcystatin may be involved in modulation of T. cruzi in intestinal tract by inhibiting par-
asite cysteine proteases, which represent the virulence factors of this protozoan.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Cystatins are reversible and tight binding inhibitors of papain-
like cysteine proteases, being widespread in plants, animals and
microorganisms [1]. Based on sequence similarity, the superfamily
of cystatins is divided in (i) type 1, or steﬁns, which contain about
100 amino acids and lack disulﬁde bridges, (ii) type 2, or cystatins,
which are proteins presenting about 120 amino acid residues and
two disulphide bridges, and (iii) type 3, or kininogens, which are
glycoproteins consisting of three homologous domains of type 2
cystatins [2,3].
Some studies have suggested that cystatins from arthropods can
be related to different processes, i.e. control of endogenous proteol-
ysis, thebalanceof host–vector immunerelationships, blood feeding
and innate immunity [4–8]. However, the role of cystatins in hema-
tophagous bugs, such as Triatoma infestans, remains unknown.
T. infestans belongs to the Triatominae subfamily and is one of
the most important vectors of Trypanosoma cruzi, a protozoan par-
asite and etiological agent of Chagas disease [9]. The disease re-
mains prevalent in many Latin American countries, affecting
about eight million people [10]. T. cruzi colonizes triatomine blood.
lsevier OA license.sucking insects’ midgut, which is considered an immune compe-
tent tissue [11]. It has been suggested that inducible immune com-
pounds from intestinal tract can modulate parasite development in
these insects [12–14].
T. cruzi relies on its major papain-like cysteine protease, cruzi-
pain, to survive and infect hosts [15,16]; however, this protozoan
is not pathogenic for triatomine bugs [17]. Therefore, cysteine pro-
tease inhibitors from vectors of T. cruzi are important candidates
for studying host–parasite interactions. In this work, we con-
structed a cDNA library from anterior midgut of T. infestans, and
a cystatin DNA fragment was identiﬁed by expressed sequence tags
(ESTs) analysis. We report for the ﬁrst time the expression and
characterization of a cystatin-like inhibitor (Tigutcystatin) from a
triatomine insect whose expression is modulated by infection with
T. cruzi.
2. Materials and methods
2.1. Materials
Bacteria and vector: Escherichia coli DH5a (F, endA1, hsdR17,
sup E44, thi1, k, recA1, gyrA96, Ø 80 d lacZD15) was used as host
for recombinant DNA manipulation. E. coli Rosetta gami strain
(D(ara–leu)7697 DlacX74 DphoA PvuII phoR araD139 ahpC galE galK
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StrR, TetR) was used as a host for protein production, and both
strains were purchased from Invitrogen (Carlsbad, CA). Primers
(Tigcysfwd: 50-GGAATTCCATATGAAGGTGTGCGCTGGATGT-30; Tig-
cysrev: 50-CGCGGATCCTTAATTACTTTTTGAAAG-30; 18sfwd - 50-
GCGCGGCGGGGGCATTCGTATTG-30 and 18srev - 50-ATCGCTGG
CTGGCATCGTTTATTTGCGG-30) were purchased from Sigma–Al-
drich. The pET14b expression vector was from Novagen (Madison,
WI). Modiﬁcation enzymes: Restriction enzymes Nde I (Promega,
Madison, WI) and BamHI (Fermentas, Hanover, MD); Taq DNA
polymerase was purchased from Fermentas (Hanover, MD). Chro-
matography columns: Ni–NTA agarose resin was obtained from
Qiagen (Hilden, Germany). HiTrap SP and Sephasil C8 were from
GE Healthcare Life (Uppsala, Sweden). Enzymes and substrates: Re-
combinant human cathepsin L (EC 3.4.22.15) was expressed in Pi-
chia pastoris as described previously [18], using a plasmid
construction kindly provided by Dr. Nagler. Precision Plus Protein
Unstained (PPPUS) and Page Ruler molecular weight markers were
purchased from Bio Rad and Fermentas, respectively. Papain (EC
3.4.22.2) and thrombin (EC 3.4.21.5) were purchased from Sigma
(St. Louis, MO, USA). Cathepsin S (3. 4. 22. 27), cathepsin V (3. 4.
22. 43) and Z-Phe-Arg-7-amido-4-methylcoumarin were pur-
chased from Calbiochem (San Diego, CA). Cruzain (3. 4. 22) and
Plasmodium falciparum culture were supplied by Dr. Luiz Juliano
Neto, Dr. Adriana K. Carmona, Dr. Piero Bagnaresi and Dr. Mario
A. Izidoro from Department of Biophysics of Escola Paulista de
Medicina – Federal University of São Paulo. Culture of T. cruzi
was kindly provided by Dr. Sergio Schenkman from Department
of Microbiology, Immunology and Parasitology of Escola Paulista
de Medicina – Federal University of São Paulo.
2.2. Insects, T. cruzi infections and tissue collection
Adult males T. infestans were reared under controlled tempera-
ture (27 ± 2.0 C), 12/12 light/dark. Insects starved for 30 days were
allowed to feed on anesthetized mice (ketamine 150 mg/kg and
xylazine 7 mg/kg) ad libitum and tissues were dissected 24 h after
feeding. For infection experiments, insects were infected orally by
feeding on anesthetized mice infected with T. cruzi Y strain ad libi-
tum.Mice infection was performed according to Kollien and Schaub
[19], and population density (1  106 parasites/mL) was deter-
mined using Neubauer chamber.
2.3. Construction and screening of a cDNA library of anterior midgut of
T. infestans
Total RNAwasextracted fromanteriormidgutof T. infestansadults
using TRIZOL reagent (Invitrogen, Carlsbad, CA). A cDNA library was
constructed using the SMART cDNA system, according to manufac-
turer’s instructions (Clontech, Palo Alto, CA). ThemRNAof T. infestans
anteriormidgut (1 lg)wasused tosynthesizeﬁrst-strandcDNA.DNA
fragments longer than 400 bp were separated by fractionation col-
umn and then collected and ligated into pTriplEX plasmid. Subse-
quently DNA fragments were submitted to phage packaging
reaction using Gigapack Gold III Packaging Extract from Stratagene
(La Jolla, CA). About 244 cDNA clones from the ampliﬁed librarywere
randomly sequenced. The DNA sequence analysis was performed
using the BLAST algorithm tools [20]. Alignment of protein sequences
was performed with the ClustalW program version 2.0 and signal
peptide was predicted using SignalP program version 3.0.
2.4. Cloning of Tigutcystatin DNA fragment into expression vector pET-
14b
The cDNA sequence encoding the mature cystatin (lacking
signal peptide) was ampliﬁed by PCR in a 50-lL reaction volumecontaining 5 pmol of gene-speciﬁc primers, 200 lM DNTPs,
1.5 mMMgCl2, and 5 U Taq DNA polymerase (Fermentas). PCR con-
ditions were: 94 C for 5 min, 94 C for 45 s, 50 C for 45 s and 72 C
for 45 s  35 cycles. DNA ﬁnal extension was carried out at 72 C
for 10 min. The PCR product was puriﬁed from 1% agarose gel using
a QIAEX II Gel Extraction kit (Qiagen, Hilden, Germany) and cloned
using pGEM-T Easy System (Promega). The cDNA encoding Tigut-
cystatin was digested with NdeI and BamHI restriction enzymes,
and sub-cloned into pET-14b vector which was previously digested
with the same enzymes above.
2.5. Expression of recombinant Tigutcystatin
Tigutcystatin was expressed by E. coli Rosetta gami strain as a
protein fused to a N-terminal 6 His tag. Previously, recombinant
Tigutcystatin was produced in 3 l LB broth medium containing
200 lg/ml ampicillin, 34 lg/ml chloramphenicol, 20 lg/ml kana-
mycin, 12 lg/ml tetracycline and one isolated colony of trans-
formed E. coli Rosetta gami. rTigutcystatin expression was
induced with 1 mM IPTG (at OD = 0.7) for 18 h at 37 C. After, cells
were harvested by centrifugation (4,000g, 20 min, 4 C) and sus-
pended in 300 ml of 50 mM Tris–HCl buffer, pH 8.0 containing
0.3 M NaCl. Cells were lysed using a French press (2000 psi). The
culture supernatant was obtained by centrifugation (13,000g,
45 min, 4 C).
2.6. Puriﬁcation of recombinant Tigutcystatin
The resulting supernatant containing rTigutcystatin was ap-
plied on a Ni–NTA agarose column pre-equilibrated with 50 mM
Tris–HCl buffer, pH 8.0, containing 0.3 M NaCl. After a washing step
with 50 mM Tris–HCl buffer, pH 8.0, containing 0.3 M NaCl and
20 mM imidazole, protein was eluted with 0.5 M imidazole in the
same Tris–HCl buffer (pH 8.0). Solution containing eluted proteins
was dialyzed against 50 mM sodium acetate buffer, pH 5.5 and rTi-
gutcystatin was further puriﬁed on a HiTrap SP cation-exchange
column connected to an ÄKTA system. The protein was eluted by
NaCl linear gradient (0–1 M) in 50 mM sodium acetate buffer, pH
5.5, at a ﬂow rate of 1 ml/min. The elution proﬁle was monitored
by measuring absorbance at 280 nm, and the fractions were tested
on human cathepsin L for inhibitory activity. All puriﬁcation steps
were analyzed by SDS–PAGE 15% [21].
2.7. Puriﬁed rTigutcystatin processing and mass spectrometry analysis
For mass spectrometry analysis, Tigutcystatin (275 lg) was
incubated with 1 U thrombin (Sigma–Aldrich) in PBS pH 7.0 at
37 C for 6 h to remove His tag. After digestion, released His tag
was removed by ﬁltration in a 3-kDa NMWL Ultracel membrane
Amicon system. Tigutcystatin without the His tail was applied to
a reverse phase chromatography in a Sephasil Peptide C8 in ÄKTA
System (GE Healthcare) equilibrated with 0.1% triﬂuoroacetic acid
(TFA), and the protein was eluted by linear acetonitrile gradient
(0–100%) at ﬂow rate of 0.7 ml/min. Molecular masses of the pro-
tease inhibitor were analyzed by MALDI-TOF mass spectrometry
on Micromass TofSpec-E spectrometer (Manchester) operating in
linear mode and calculated from them/z peaks in the charge-distri-
bution proﬁles of the multiple charged ions.
2.8. Dissociation constant (Ki) determination
Proteolytic enzymes, papain, cathepsin L, cathepsin V, cathep-
sin S, cruzain and cathepsins-L like from supernatant of culture of
T. cruzi trypomastigotes and P. falciparum were pre-activated with
1 mM DTT (ﬁnal concentration) in 50 mM sodium acetate buffer,
pH 5.5, containing 60 mM NaCl for 10 min at 37 C. Afterwards,
AB
Fig. 1. Analysis of Tigutcystatin amino acid sequence. (A) Predicted amino acid sequence of Tigutcystatin. Putative signal peptide is underlined. Conserved amino acids of
Tigutcystatin are boxed and stop codon is represented by an asterisk. (B) Alignment of putative amino acid sequence of Tigutcystatin with other insect cystatins. Identical
amino acids are black boxed and similar amino acids are gray boxed. Speregrina = Sarcophaga peregrina (Flesh ﬂy) sarcocystatin A-alpha; Genbank number J02847.
Dmelanogaster = Drosophila melanogaster (Fruit ﬂy) cystatin-like; Genbank number NM_057508. Ofasciatus = Oncopeltus fasciatus (Seed-feeding bug) salivary secreted
cystatin 3 precursor; Genbank number EF382731. Asterisks indicate conserved amino acid residues.
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tions of His-tag Tigutcystatin for 10 min at 37 C and the sub-
strate Z-Phe-Arg-MCA (50 lM-ﬁnal concentration) was added.
The measurement of absorbance was made at 380 nm excitation
and 460 nm emission. Dissociation constant was calculated by ﬁt-
ting the steady-state velocities to the Morrison equation (Vi/Vo =
1  {Et + It + Ki  [(Et + It + Ki)2  4EtIt]1/2}/2Et) for tight-binding
inhibitors using a nonlinear regression analysis [22].2.9. Tigutcystatin expression proﬁle after infection with T. cruzi
After feeding (24 h post blood meal), insect tissues (anterior
midgut, posterior midgut salivary glands and fat body,) were dis-
sected for semi quantitative PCR of Tigutcystatin expression. cDNA
synthesis was performed using total RNA and ImProm-II™ Reverse
Transcription System (Promega) following the manufacturer’s
guidelines. Quantitative Real time PCR was performed following
methods described by Livak and Schimittgen [23] for relative
quantiﬁcation of amounts of transcripts. The cDNAs from anterior
midgut of uninfected T. infestans as well as infected with T. cruzi
were quantiﬁed using SYBR Green PCR Master Mix (Applied Bio-
systems) in a 7500 Fast Real-Time PCR System (Applied Biosys-
tems). 18S ribosomal RNA was used as internal control. The PCR
program was 40 cycles at 94 C (1 min) and 60 C (1 min), and
0.3 lM primers were used. All values are represented as
mean ± standard deviation. Two-tailed unpaired t -test was con-
ducted for statistical analysis and a signiﬁcant difference was ac-
cepted at P < 0.05.3. Results
3.1. Nucleotide sequence analysis and cloning of DNA coding for
Tigutcystatin
A putative cystatin was found among 244 clones sequenced
from a midgut cDNA library. The cDNA fragment encoding a puta-
tive cystatin named Tigutcystatin (T. infestans midgut cystatin)
was cloned and sequenced. The nucleotide sequence of Tigutcyst-
atin, shown in Fig. 1A, presented a 363-bp ORF encoding a protein
with 121 amino acid residues. The amino acid sequence analysis
revealed the presence of ﬁve cysteine residues, a signal peptide
(underlined in Fig. 1A) and a cleavage site between amino acids
25 and 26. The mature protein consisted of 288 bp encoding a pro-
tein with 96 amino acid residues with a calculated molecular
weight of 11 kDa and isoelectric point (pI) of 8.64. The amino acid
sequence of Tigutcystatin showed about 30% of similarity with
other insect cystatins, including conserved motifs present in the
Cystatin type 2 family (Fig. 1B).3.2. Expression and puriﬁcation of recombinant Tigutcystatin
The cDNA fragment encoding to Tigutcystatin was cloned in pET
14b vector and the protein expressed fused to an amino-terminal
His tag. Puriﬁcation of 8 mg of starting protein afforded to obtain
0.9 mg of rTigutcystatin. The recombinant protein was subjected
to afﬁnity chromatography on Ni–NTA (Fig. 2A) followed by ion ex-
change chromatography on Hitrap SP column (Fig. 2B). SDS–PAGE
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Fig. 2. rTigutcystatin puriﬁcation. (A) The supernatant of culture of E. coli Rosetta gami strain containing Tigutcystatin (8 mg) was applied on Ni–NTA agarose column and the
fraction with inhibitory activity (represented by a black bar) were pooled and applied on a HiTrap SP column (B) and the proteins were eluted with linear gradient of NaCl (0–
1 M). (C) rTigutcystatin analysis by SDS–PAGE (15%). M – molecular weight marker (PPPUS), (1) His-Tigutcystatin from Pool 2 of HiTrap SP; (2) His-Tigutcystatin from Pool 1
of Hitrap SP. (3) Pool from Ni–NTA agarose chromatography. (4) supernatant of bacteria culture. (5) pellet of bacteria. Puriﬁed Tigutcystatin is indicated by a black arrow in
the ﬁgure.
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13.5 kDa (Fig. 2C, lane 1, black arrow).
Puriﬁed His-Tigutcystatin was digested with thrombin to re-
move His tag portion. The resulting protein appeared as a single
band at 11 kDa in SDS–PAGE electrophoresis (Fig. 3A). Then, the
protein was concentrated and applied on a reverse phase chroma-
tography and a protein peak obtained (Fig. 3B, black arrow) was
submitted to MALDI-TOF analysis, showing a molecular mass of
10,137 Da (Fig. 3C).3.3. Tissue-speciﬁc expression
Tigutcystatin expression proﬁle analysis using different tissues
was performed with cDNA preparation from anterior midgut, pos-
terior midgut, fat body and salivary glands and speciﬁc primers for
Tigutcystatin cDNA fragment by PCR. The inhibitor expression was
highest in anterior midgut, although Tigutcystatin expression was
also observed in posterior midgut. Nevertheless, it was absent in
salivary gland and fat body (Fig. 4A). 18S ribosomal gene speciﬁc
primers were used as an endogenous control.3.4. Quantitative Real time PCR of Tigutcystatin gene expression
cDNA of infected and uninfected insects were used in a quanti-
tative RT-PCR for Tigutcystatin expression analysis. Tigutcystatin
expression was signiﬁcantly up-regulated (4-fold) in infected in-
sects, when compared with uninfected animals (Fig. 4B).3.5. rTigutcystatin inhibition proﬁle
To investigate Tigutcystatin speciﬁcity, inhibition assays to-
wards papain-like enzymes were performed (Table 1). Puriﬁed
rTigutcystatin was able to inhibit all tested enzymes, but with high
selectivity to cruzain from T. cruzi (Ki = 3.29 nM) and human
cathepsin L (Ki = 3.78 nM). However, the inhibitor was compara-
tively less effective to inhibit cathepsin V (Ki = 21.49 nM) and
cathepsin S (Ki = 25.97 nM).4. Discussion
The present study describes expression, puriﬁcation and char-
acterization of a cystatin-like inhibitor from the Chagas disease
vector T. infestans. This is the ﬁrst time a cystatin is characterized
in a Triatomine bug. The putative amino acid sequence indicates
that this inhibitor belongs to type 2 cystatins (Fig. 1A), which in-
clude secretory proteins presenting a signal peptide and a two
characteristic disulphide bridges [24]. The alignment of Tigutcyst-
atin amino acid sequence with other insect cystatins showed
highly conserved regions (Fig. 1B), including a N-terminal glycine
residue, a central motif QxVxG (x represents any amino acid),
and the dipeptide PW near the carboxi-terminal region. All these
structural features are important cysteine proteases inhibition
sites [25,26].
In this study, Tigutcystatin mRNA was detected in small intes-
tine, but it was hardly detected in anterior midgut (Fig. 4A). More-
over, Tigutcystatin showed a signiﬁcant up-regulation in stomach
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Tigutcystatin thrombin processed. (B) Mass spectrometry analysis. The peak obtained from reverse-phase was submitted to mass spectrometry in a Micromass TofSpec E. (C)
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Fig. 4. Tissue speciﬁc and immune challenge expression proﬁle of Tigutcystatin. (A) Semi-quantitative PCR analysis of Tigutcystatin expression in different tissues of
T. infestans. Electrophoresis on agarose gel (1%) of PCR products using cDNA preparation of: (1) anterior midgut; (2) posterior midgut; (3) fat body; (4) salivary glands. (B)
Quantitative Real time PCR. Relative amount of mRNA induced by T. cruzi infection. Adult insects infected with T. cruzi and uninfected T. infestans were used for analysis. All
data were normalized to ribosomal 18S, representing the mean (n = 3) of identical triplicates ± standard deviation. Two-tailed unpaired t-test (P < 0.05) was performed for
statistical analysis. Signiﬁcant differences are represented by two asterisks.
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Table 1
Dissociation constants (Ki) of Tigutcystatin for several cysteine
proteases.
Enzyme Ki (nM)
Cruzain 3.29
Human cathepsin L 3.78
Cathepsins L-like T. cruzi 4.21
Cathepsins-like P. falciparum 6.26
Papain 6.68
Human cathepsin V 21.49
Human cathepsin S 25.97
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more than one role of this molecule in T. infestans. Since triatomine
insects use cathepsins for protein digestion in posterior midgut
[27], Tigutcystatin could be also involved in regulation of endoge-
nous cysteine proteases in stomach, thus controlling undesired
proteolysis in this compartment. On the other hand, cystatins are
related to innate immunity in insects [4]. Tigutcystatin might also
have a defensive role when T. infestans is infected with T. cruzi by
inhibiting cruzipain, a parasite cysteine protease used to invade
host cells [28].
Regarding inhibition properties, kinetic assays revealed that
Tigutcystatin binds tightly to cruzain, the recombinant cruzipain
truncated at C-terminal [28] and cathepsins L-like present in T. cru-
zi trypomastigotes and P. falciparum (Table 1). Tight inhibition of
cruzipain by other recombinant type 2 cystatins (human cystatin
C and chicken cystatin) has also been demonstrated by Stoka, Nyc-
ander, Lenarcic et al. [29]. Together, these data support the evi-
dence for the defensive role of Tigutcystatin against protozoan
parasites. Tigutcystatin was less effective to inhibit cathepsins V
and S, indicating that this inhibitor might be able to discriminate
cathepsins L-like of parasites from other cathepsins.
In spite of the protozoan cathepsins L-like functions, cruzipain
has also been associated to T. cruzi survival in hosts [30]. The
expression of a cysteine protease inhibitor in T. infestans midgut
is noteworthy, which is colonized by T. cruzi. Thus, Tigutcystatin
might be also important to modulate T. cruzi colonization inside
the insect midgut.
Tigutcystatin may also be involved in interaction of T. infestans–
Trypanosoma rangeli, since this protozoan parasite is transmitted
by species from the genus Rhodnius (via hemolymph invasion
and salivary glands establishment), though it is not transmitted
by Triatoma species [31]. It has been suggested that proteases
are involved in the ability T. rangeli demonstrates to cross midgut
membranes and invade hemolymph and salivary glands [17]. Even
though differences in susceptibility of Triatoma and Rhodnius
genus remain unknown, in Triatoma species T. rangeli seems to
be restricted to the digestive tube [32]. Since rangelipain, the main
cathepsin L-like from T. rangeli, shares high identity with cruzipain
[33], we hypothesize that Tigutcystatin might be involved in
limitation of T. rangeli inside the digestive tract by inhibiting
rangelipain. However, further studies are needed to demonstrate
the interactions between Tigutcystatin and T. rangeli cysteine
proteases.
In summary, Tigutcystatin was able to inhibit parasite cysteine
proteases, being up-regulated in response to T. cruzi infection.
From our results, we can suggest that Tigutcystatin might be in-
volved on immune processes concerning T. infestans–T. cruzi
interactions. Our future studies may also help elucidate these vec-
tor–parasite relationships.
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